http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108602821-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cadfb09acd5bddac739df8e712442b0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
filingDate 2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45304ccaa92e65a668b136c0415f6a08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e5315a76207fd3878c98be95b005dc6
publicationDate 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108602821-A
titleOfInvention 1H-imidazo[4,5-B]pyridyl and 2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridyl heterocyclic BET bromodomain inhibitors
abstract Disclosed herein are substituted 1H-imidazo[4,5-b]pyridyl and 2-oxo-2,3-dihydro-1H-imidazolo which are useful as inhibitors of BET protein function by binding to bromodomains [4,5-b]pyridyl heterocyclic compounds, compositions comprising said compounds and their use in therapy. These compounds are useful in the treatment of diseases and conditions such as cancer, autoimmune disease, inflammation and cardiovascular disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113264930-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113264930-B
priorityDate 2015-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012116145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015002754-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009111277-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014151729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015022332-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013056070-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID550687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467396413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467841666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466834672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467330373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467717654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416006634

Total number of triples: 35.